Science Explorer Back to mapMap
Discussion
Researcher · Kanazawa Medical University · Japan

Misuzu Saiki

Misuzu Saiki publishes mostly in Neurology, Cellular and Molecular Neuroscience and Molecular Biology, on topics such as Genetic Neurodegenerative Diseases, Neurological and metabolic disorders and Parkinson's Disease Mechanisms and Treatments.

OpenAlex
World rank
#4,185,129
of 7,710,434 ranked researchers
Rank in Japan
#115,320
of 383,136
Works
16
Citations
561
Citations per work
35.1
h-index
10
i10-index 11Top 60% in Neurology (Medicine)
Misuzu Saiki

What does Misuzu Saiki research?

Misuzu Saiki's work is mostly in Medicine (38%), Neuroscience (16%), Biochemistry, Genetics and Molecular Biology (13%).

Health Sciences: 6 works · 37.8% of their workMedicine: 6 works · 37.8% of their workNeurology: 4 works · 22.2% of their workEndocrinology, Diabetes and Metabolism: 1 works · 8.9% of their workHematology: 1 works · 6.7% of their workLife Sciences: 5 works · 33.3% of their workNeuroscience: 2 works · 15.6% of their workCellular and Molecular Neuroscience: 2 works · 15.6% of their workBiochemistry, Genetics and Molecular Biology: 2 works · 13.3% of their workMolecular Biology: 2 works · 13.3% of their workImmunology and Microbiology: 1 works · 4.4% of their workImmunology: 1 works · 4.4% of their workEverything else: 5 works · 28.9% of their workTHEIR WORKMisuzu Saiki16works
Life Sciences33%Health Sciences38%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine637.8%
    1. Neuroscience215.6%
    2. Biochemistry, Genetics and Molecular Biology213.3%
    3. Immunology and Microbiology14.4%
  3. Everything else528.9%
  1. 1Neurology22% of their works
  2. 2Cellular and Molecular Neuroscience16% of their works
  3. 3Molecular Biology13% of their works
  4. 4Endocrinology, Diabetes and Metabolism9% of their works
  5. 5Hematology7% of their works
  6. 6Immunology4% of their works

Research topics

Which keywords describe Misuzu Saiki's research?

The keywords of their largest research topics: Mitochondrial Dysfunction, Parkinson's Disease, Basal Ganglia, Dopaminergic Neurons, Huntington's Disease, Neurodegeneration, Neurological Disorders and Protein Aggregation.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.

All 22 words, with their numbers
  1. Mitochondrial Dysfunction82 topics
  2. Parkinson's Disease83 topics
  3. Basal Ganglia72 topics
  4. Dopaminergic Neurons52 topics
  5. Huntington's Disease51 topic
  6. Neurodegeneration52 topics
  7. Neurological Disorders52 topics
  8. Protein Aggregation51 topic
  9. Chorea41 topic
  10. Hyperglycemia41 topic
  11. Deep Brain Stimulation31 topic
  12. Genetic Risk Factors31 topic
  13. Subthalamic Nucleus31 topic
  14. a-Synuclein31 topic
  15. ADAR Deaminases21 topic
  16. Alloimmunization21 topic
  17. Blood Groups21 topic
  18. NR4A221 topic
  19. Nurr121 topic
  20. RNA Editing21 topic
  21. Biochemical Genetics11 topic
  22. Metabolic Disorders11 topic

Where does Misuzu Saiki work?

Misuzu Saiki's main affiliation in the publication record is Kanazawa Medical University, Japan.

How many publications and citations does Misuzu Saiki have?

OpenAlex counts 16 works and 561 citations for Misuzu Saiki, an h-index of 10, ranking #4,185,129 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Misuzu Saiki. Posts are plain text and can be reported.